newsfilter
← Latest News
GlobeNewswire·

Viracta Therapeutics to Present at the 2023 SVB Securities Global Biopharma Conference

SAN DIEGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide,